|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity & Clinical Trials Insight 2026 Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. “Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity & Clinical Trials Insight 2026” Report Highlights: Global FGFR ... Global Fibroblast Growth Factor Receptor 4 Market Report 2020 ... Segmentation BLU-9931 BMS-986036 Erdafitinib ES-135 FGF-401 Industry Segmentation ... Global Fibroblast Growth Factor Receptor 4 Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 ... , covers BLU-9931 BMS-986036 Erdafitinib ES-135 FGF-401 Others Market ... Global Bladder Cancer Targeted Drug Market Growth (Status and Outlook) 2023-2029 ... by type Atezolizumab (Tecentriq) Avelumab (Bavencio) Erdafitinib (Balversa) Other Segmentation by application Hospital ... Global Targeted Therapy for Bladder Cancer Market Growth (Status and Outlook) 2023-2029 ... by type Atezolizumab (Tecentriq) Avelumab (Bavencio) Erdafitinib (Balversa) Other Segmentation by application Hospital ... Global Bladder Cancer Targeted Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031 ... by Type - Atezolizumab (Tecentriq) - Avelumab (Bavencio) - Erdafitinib (Balversa) - Other Market segment by Application ... Global Targeted Therapy for Bladder Cancer Market 2025 by Company, Regions, Type and Application, Forecast to 2031 ... by Type - Atezolizumab (Tecentriq) - Avelumab (Bavencio) - Erdafitinib (Balversa) - Other Market segment by Application ... Global Fibroblast Growth Factor Receptor 4 Market Growth 2025-2031 ... by Type: BLU-9931 BMS-986036 Erdafitinib ES-135 FGF-401 Others Segmentation ... Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2018 SUMMARY Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Fibroblast growth factor receptor 4 is a protein encoded by the FGFR4 gene. It ... Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H1 2018 Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H1 2018 SUMMARY According to the recently published report 'Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H1 2018'; Fibroblast ... Fibroblast Growth Factor Receptor 4 Market - Global Outlook and Forecast 2022-2028 ... , 2021 (%) BLU-9931 BMS-986036 Erdafitinib ES-135 FGF-401 Others Global ... Growth Factors (Blood and Tissue): Market Research Report This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following growth factor Types: Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins), and Tissue Growth Factors ... Global Wireless Doorbells Market Growth 2025-2031 The global Wireless Doorbells market size is predicted to grow from US$ 1861 million in 2025 to US$ 2521 million in 2031; it is expected to grow at a CAGR of 5.2% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy ... Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) ... Global Urinary Tract Cancer Market Size study & Forecast, by Cancer Type (Bladder Cancer, Urethral cancer and Ureteric and Renal Pelvic Cancer), Treatment Type (Chemotherapy, and Immunotherapy), and Distribution Channel (Retail Pharmacy, and Online Pharmacy) and Regional Analysis, 2022-2029 ... ) approval for the drug Balversa (erdafitinib). This new drug is intended for ... 2023-2028 Global and Regional Fibroblast Growth Factor Receptor 4 Industry Status and Prospects Professional Market Research Report Standard Version ... By Types: BLU-9931 BMS-986036 Erdafitinib ES-135 FGF-401 Others By Applications ... Global Bladder Cancer Targeted Drug Market Research Report 2024(Status and Outlook) ... (by Type) Atezolizumab (Tecentriq) Avelumab (Bavencio) Erdafitinib (Balversa) Other Market Segmentation (by Application ... Global Targeted Therapy For Bladder Cancer Market Research Report 2025(Status and Outlook) ... (by Type) Atezolizumab (Tecentriq) Avelumab (Bavencio) Erdafitinib (Balversa) Other Market Segmentation (by Application ... Bladder Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major bladder cancer markets reached a value of US$ 3.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.4 Billion by 2034, exhibiting a growth rate (CAGR) of 3.09% during 2024-2034. The bladder cancer market has been ... Urothelial Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major urothelial carcinoma markets are expected to exhibit a CAGR of 12.34% during 2024-2034. The urothelial carcinoma market has been comprehensively analyzed in IMARC's new report titled "Urothelial Carcinoma Market: Epidemiology, Industry Trends, ... |